2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Stomach Neoplasms
2
Pseudomyxoma Peritonei
2
Ototoxicity
2
Neurofibromatosis 1
2
Neoplasms
2
Liver Neoplasms
2
Hearing Loss
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Ulcer
1
Tongue Neoplasms
1
Tomaculous neuropathy
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Renal Artery Obstruction
1
Radiation-Induced Mucositis
1
Radiation Pneumonitis
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Primary Graft Dysfunction
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Prednisone
5
Mammography
5
Colonoscopy
5
Biopsy
5
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Lenalidomide
4
Biopsy, Fine-Needle
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Melphalan
3
Liquid Biopsy
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Urination
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Acetylcysteine
×
Clear all
NCT04460521
2024-08-23
ACTS
Nova Scotia Health Authority
Phase 4
Recruiting
240 enrolled